Rituximab in the treatment of secondary-progressive multiple sclerosis

被引：0
|
作者：
Perrone, C. [1 ]
Berriosmorales, I. [1 ]
Beretich, B. [2 ]
Riskind, P. [1 ]
Ionete, C. [1 ]
机构：
[1] Univ Massachusetts, Sch Med, Worcester, MA USA
[2] Maine Med Ctr, Portland, ME 04102 USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2014年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P286
引用
收藏
页码：194 / 194
页数：1
相关论文
共 50 条
  • [41] Case-report: Cladribine and alemtuzumab haematological treatment of chronic lymphatic leukemia and stabilizing effect on secondary-progressive multiple sclerosis
    Havrdova, Eva
    Krasulova, Eva
    Kozak, Tomas
    Cerna, Olga
    JOURNAL OF NEUROIMMUNOLOGY, 2008, 203 (02) : 142 - 142
  • [42] Novel integrative approach combining patient, physician and empirical assessments for diagnosing secondary-progressive multiple sclerosis
    Meier, D. Piani
    Bennett, B.
    Tolley, C.
    Kilgariff, S.
    Tomic, D.
    Ziemssen, T.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 740 - 741
  • [43] Relapsing-remitting and secondary-progressive multiple sclerosis patients differ in decoding others' emotions by their eyes
    Argento, Ornella
    Spano, Barbara
    Serra, Laura
    Incerti, Chiara Concetta
    Bozzali, Marco
    Caltagirone, Carlo
    Francia, Ada
    Fratino, Mariangela
    Nocentini, Ugo
    Piacentini, Chiara
    Quartuccio, Maria Esmeralda
    Pisani, Valerio
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 (02) : 505 - 514
  • [44] Glutathione levels in the brains of patients with secondary-progressive multiple sclerosis are reduced by magnetic resonance spectroscopy measures
    Lynch, Sharon
    Lee, Sang-Pil
    Choi, In-Young
    MULTIPLE SCLEROSIS, 2009, 15 (11): : 1404 - 1405
  • [45] Rituximab and glatiramer acetate in secondary progressive multiple sclerosis: A randomized clinical trial
    Cheshmavar, Masoumeh
    Mirmosayyeb, Omid
    Badihian, Negin
    Badihian, Shervin
    Shaygannejad, Vahid
    ACTA NEUROLOGICA SCANDINAVICA, 2021, 143 (02): : 178 - 187
  • [46] The role of brain glucose metabolism in the development of cognitive dysfunctions in patients with remitting and secondary-progressive multiple sclerosis
    Shkilnuk, G. G.
    Ilves, A. G.
    Kataeva, G. V.
    Prakhova, L. N.
    Reznikova, T. N.
    Seliverstova, N. A.
    Stolyarov, I. D.
    ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2012, 112 (02) : 41 - 46
  • [47] Demyelinating plaques in relapsing-remitting and secondary-progressive multiple sclerosis: Assessment with diffusion MR imaging
    Scanderberg, AC
    Tomaiuolo, F
    Sabatini, U
    Nocentini, U
    Grasso, MG
    Caltagirone, C
    AMERICAN JOURNAL OF NEURORADIOLOGY, 2000, 21 (05) : 862 - 868
  • [48] Treatment of active secondary progressive multiple sclerosis with treosulfan
    H. Wiendl
    B. C. Kieseier
    R. Weissert
    H. A. Mylius
    U. Pichlmeier
    H.-P. Hartung
    A. Melms
    W. Kuker
    M. Weller
    Journal of Neurology, 2007, 254 : 884 - 889
  • [49] New outlook for the treatment of secondary progressive multiple sclerosis
    Noga, Magdalena
    Bartosik-Psujek, Halina
    AKTUALNOSCI NEUROLOGICZNE, 2015, 15 (03): : 130 - 134
  • [50] Treatment of active secondary progressive multiple sclerosis with treosulfan
    Wiendl, Heinz
    Kieseier, Bernd C.
    Weissert, Robert
    Mylius, Heidrun A.
    Pichlmeier, Uwe
    Hartung, Hans-Peter
    Melms, Arthur
    Kuker, Wilhelm
    Weller, Michael
    JOURNAL OF NEUROLOGY, 2007, 254 (07) : 884 - 889
12345